While chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as “chemo brain.” These effects resemble the memory and learning problems seen in older adults.
read more
The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those with a rare muscle-weakness disease known as Myasthenia Gravis.
read more
People 55 and older who exhibit signs and symptoms of Alzheimer's disease can now receive the test, which is more than 90% accurate in diagnosing the disease, through a blood draw ordered by their physician.
read more
A new county-level dataset reveals a national decline in the measles-mumps-rubella (MMR) vaccination rate among U.S. children since the start of the COVID-19 pandemic.
read more
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1.
read more
The European Medicines Agency has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date.
read more
People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a study of more than 1 million people.
read more
Researchers found that the vaccine not only targeted the COVID-19 virus, it also unexpectedly helped to reduce and control innate inflammation to other bacterial and fungal pathogens not related to the vaccine target.
read more
Every year a person experienced an incremental increase in insomnia symptoms, their risk for becoming disabled in some aspect of their daily life increased by 20%.
read more
Enteroviruses cause everything from polio to meningitis. An effective treatment could help reduce the risk of this global health problem.
read more
A virulent strain of antibiotic-resistant superbug that causes severe disease has been found circulating in a Malaysian hospital, posing significant challenges to global public health, a new study reveals.
read more
Applying 25 percent trade tariffs to these pharmaceuticals could add $750 million in cost to the U.S. market and has the potential to significantly disrupt drug supply over the long term.
read more
As antibiotic resistance continues to grow, some researchers have begun investigating “alternative” therapies—methods that do not rely on additional, stronger antibiotics.
read more
To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new biomanufacturing platform called Phytogene.
read more
Researchers once thought that microRNAs were just junk in cells. Now it may help us better understand how an organism reacts to viral infections.
read more